Search clinical trials for: VNRX-5133
Total 0 results
Nothing found
Sponsors and Collaborators
- Northern California Melanoma Center
- CTC Bio, Inc.
- New York State Health Foundation
- Ionis Pharmaceuticals
- Montreal Neurological Institute and Hospital
- Zahra Rabbani Khah
- European Network For Smoking and Tobacco Prevention
- Jeffrey W. Clark, MD
- Rex Bionics Plc
- Marilia Medicine School
- Health Parametrics Inc.
- John Granton
- Wushan County People's Hospital
- Jeffrey Rudolph
- MingSight Pharmaceuticals Pty Limited
- Medtronic Atrial Fibrillation Solutions
- Mitchell Scheiman
- Honda R and D Americas, Inc.
- The Third Hospital of Changsha
- Kawin Technology Share-holding Co., Ltd.
- View Full List
Medical Conditions
- Nutritional Edema
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Low Birthweight, Extremely (999 Grams or Less)
- Radial Artery Catheterization
- Suspected Neonatal Encephalopathy
- Moderate to Severe Functional Impairments
- Pediatric Anaplastic Large Cell Lymphoma
- Fecal Elastase-1 Test
- Myeloproliferative Disease
- Periodontology
- Heart Defect, Congenital
- Acute Necrotizing Encephalopathy
- Improved Vocal Fold Status
- Postmenopausal Diabetes
- Ketamine Treatment
- Influenza and Other Novel Respiratory Viruses
- Idiopathic Gastric Stasis
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Canthal Lines
- Pertussis Immunisation
- View Full List
Drug Interventions
- Hydroxychloroquine
- Rifaximin
- Pentostatin
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Bendamustine
- Postoperative analgesia management
- Fludarabine
- Toripalimab plus Anlotinib
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Nimotuzumab
- ESK981
- AZD7798
- 200 µg doxorubicin-containing MNA
- Levcromakalim
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- CKD-519
- Ombrabulin (AVE8062)
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Levobupivacaine, clonidine
- View Full List
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Gabon
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Netherlands
- Contract Research Organizations in New Zealand
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Qatar
- Contract Research Organizations in Senegal
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Togo
- CRO list by country